3Laurencet FM, Doucet A, Lydiate V, et al. Quality evaluation of lateletpheresis using the New Amincus(Baxter) cell sperator., evaluation of CD 62 expression. J Clin Apheresis , 1998,13 (2):47.
4Lutz P,Dzik WH. Large-volumn hemocytometer chamber for accurate aounting of WBC in WBC-reduced platelet: validation and application for qulity control of WBC-reduced platelets prepared by apheresis and fillration, Transfusion, 1993,33 (5) : 409.
5BlahaM,Varvarovsky L,PeckaM,et,al. Preparation of thrombocyte concentrats in the travenol CS-plus separator factors affecting the fhrombocyte yield and presence of leckcytes. Vnitr Lek,1991,37(1):73.
6Seagraves P, Brown R, Anderson TK, et al. Use of the CS-plus blood cell separator with the TNX-6 separation chamber for the collection of platelets with low residual leukocytes. Transfution,1991,31 (Suppl):22.
7Bertholf MF, Mintz PD. Comparision of plateletpheresis using two cell separators and identical donors. Tranfusion, 1989,29(6):521.
8Abreu ED,Strause RG,Corclie DG, et al. Providing leukocytereduced platelets using the CS-3000plus. J Clin Apheresis ,1996,11(1) :27.
9Kretschmer V. Side-effects and technical problem in cytapheresis with cell separators: results of a retrosrectivs multicenterstudy. Infusionsther Klin Ernahr, 1987,14(Suppl 4) : 7.
10Rintels PB, Kenney RM, Crowley JP, et al. Therapeutiu support of the patient with thrombocytopenia. Hematol/Oncol Clin North Am,1994,8(6):1131.
9Flesch BK, Adamzik I, Steppat D, et al. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort. Transfusion, 2010,50 : 894 -901.
